FDA lifts hold on Vertex's diabetes stem cell therapy after just two months under the microscope

Vertex Pharmaceuticals has received the FDA go-ahead to continue studies for its diabetes stem cell therapy.

The treatment, which Vertex has attempted to describe as …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA lifts hold on Ver­tex's di­a­betes stem cell ther­a­py af­ter just two months un­der the mi­cro­scope